Clinical Trial Update: Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2) [Phase 1]

View source ↗

Summary

Phase 1 AMEERA-2 trial of oral amcenestrant in Japanese postmenopausal patients with advanced breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• amcenestrant (SAR439859) (amcenestrant)

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED